Neuraxis, INC 8-K

What Happened
Neuraxis, Inc. announced (via Form 8‑K) that it authorized and declared a stock dividend for the second quarter of 2026 on its Series B Preferred Stock. The dividend will be paid in shares of the company’s common stock and is payable on July 29, 2026 to holders of record as of the close of business on July 21, 2026.

Key Details

• The dividend covers accrued and unpaid Series B Preferred dividends from April 1, 2026 through the record date; each holder’s number of common shares = accrued dividend ÷ $2.38.
• Approximately 80,463 shares of common stock are expected to be issued in connection with the dividend.
• No fractional shares will be issued; holders entitled to fractional shares will receive cash (without interest or deduction) equal to $2.38 multiplied by the fraction of one Series B Preferred share they own.
• Series B Preferred and Common Stock each have par value $0.001 (as stated in the filing).

Why It Matters
This action converts accrued preferred dividends into common shares, which can increase the company’s outstanding common share count (dilution). Investors should note the record date (July 21, 2026) and the payment date (July 29, 2026). The filing does not report earnings, revenue or executive changes—its primary investor impact is the issuance of roughly 80,463 common shares and the cash-in-lieu process for fractional entitlements.